| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | 10%+ Owner | Voting Common Stock | 19.7M | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series A-1 Preferred Stock | 0 | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series B-1 Preferred Stock | 0 | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Oct 28, 2025 | Indirect | ||
| MapLight Therapeutics, Inc. | 10%+ Owner | Series D Preferred Stock | 0 | Oct 28, 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MLPT | MapLight Therapeutics, Inc. | Oct 28, 2025 | 8 | $92.5M | 4 | Oct 29, 2025 | 10%+ Owner |
| MLPT | MapLight Therapeutics, Inc. | Oct 25, 2025 | 0 | $0 | 3 | Oct 27, 2025 | 10%+ Owner |